Literature DB >> 8846827

Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.

M J Garcia-Barrado1, J C Jonas, P Gilon, J C Henquin.   

Abstract

The following sequence of events is thought to underlie the stimulation of insulin release by hypoglycaemic sulphonylureas. Interaction of the drugs with a high-affinity binding site (sulphonylurea receptor) in the B-cell membrane leads to closure of ATP-sensitive K+ channels, depolarization, opening of voltage-dependent Ca2+ channels, Ca2+ influx and rise in cytoplasmic [Ca2+]i. Recent experiments using permeabilized islet cells or measuring changes in B-cell membrane capacitance have suggested that sulphonylureas can increase insulin release by a mechanism independent of a change in [Ca2+]i. This provocative hypothesis was tested here with intact mouse islets. When B-cells were strongly depolarized by 60 mM K+, [Ca2+]i was increased and insulin secretion stimulated. Under these conditions, tolbutamide did not further increase [Ca2+]i or insulin release, whether it was applied before or after high K+, and whether the concentration of glucose was 3 or 15 mM. This contrasts with the ability of forskolin and phorbol 12-myristate 13-acetate (PMA) to increase release in the presence of high K+. Tolbutamide also failed to increase insulin release from islets depolarized with barium (substituted for extracellular Ca2+) or with arginine in the presence of high glucose. Glibenclamide and its non-sulphonylurea moiety meglitinide were also without effect on insulin release from already depolarized B-cells. In the absence of extracellular Ca2+, acetylcholine induced monophasic peaks of [Ca2+]i and insulin secretion which were both unaffected by tolbutamide. Insulin release from permeabilized islet cells was stimulated by raising free Ca2+ (between 0.1 and 23 microM). This effect was not affected by tolbutamide and inconsistently increased by glibenclamide. In conclusion, the present study does not support the proposal that hypoglycaemic sulphonylureas can increase insulin release even when they do not also raise [Ca2+]i in B-cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8846827     DOI: 10.1016/0014-2999(95)00806-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism.

Authors:  R J Ferry; A Kelly; A Grimberg; S Koo-McCoy; M J Shapiro; K E Fellows; B Glaser; L Aguilar-Bryan; D E Stafford; C A Stanley
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

2.  Capacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans.

Authors:  Sven Göpel; Quan Zhang; Lena Eliasson; Xiao-Song Ma; Juris Galvanovskis; Takahiro Kanno; Albert Salehi; Patrik Rorsman
Journal:  J Physiol       Date:  2004-02-13       Impact factor: 5.182

3.  Relationships between the Na(+)/K(+) pump and ATP and ADP content in mouse pancreatic islets: effects of meglitinide and glibenclamide.

Authors:  A Elmi; L A Idahl; J Sehlin
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Potentiation of quantal catecholamine secretion by glibenclamide: evidence for a novel role of sulphonylurea receptors in regulating the Ca(2+) sensitivity of exocytosis.

Authors:  S C Taylor; E Carpenter; M L Roberts; C Peers
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

Review 5.  Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets.

Authors:  A Sjöholm
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.633

6.  The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta cells is mediated by a 65-kDa mdr-like P-glycoprotein.

Authors:  S Barg; E Renström; P O Berggren; A Bertorello; K Bokvist; M Braun; L Eliasson; W E Holmes; M Köhler; P Rorsman; F Thévenod
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

7.  Stimulation of bile duct epithelial secretion by glybenclamide in normal and cholestatic rat liver.

Authors:  M H Nathanson; A D Burgstahler; A Mennone; J A Dranoff; L Rios-Velez
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

8.  Activators of PKA and Epac distinctly influence insulin secretion and cytosolic Ca2+ in female mouse islets stimulated by glucose and tolbutamide.

Authors:  Jean-Claude Henquin; Myriam Nenquin
Journal:  Endocrinology       Date:  2014-06-30       Impact factor: 4.736

9.  Assessment of re-aggregated human pancreatic islets for secondary drug screening.

Authors:  K Ramachandran; X Peng; K Bokvist; L Stehno-Bittel
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Impaired Ca(2+) signaling in β-cells lacking leptin receptors by Cre-loxP recombination.

Authors:  Eva Tudurí; Jennifer E Bruin; Heather C Denroche; Jessica K Fox; James D Johnson; Timothy J Kieffer
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.